Acrivon Therapeutics, Inc. (ACRV): SC 13G filed Feb 14, 2023

Form type

SC 13G

Filing date

Feb 14, 2023

Accession number

0000902664-23-001677

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)